drugset / Trial / NCT03597555

Sodium Oxybate in Idiopathic Hypersomnia

NCT03597555

Phase 2/3 Completed 48 enrolled University Hospital, Montpellier
RandomizedParallel-groupTriple-blindTreatment

Summary

this study evaluates of the efficacy of sodium oxybate on excessive daytime sleepiness using Epworth sleepiness scale over 8 weeks compared to placebo

Timeline

Start
2018-10-18
Primary completion
2023-04-12
Completion
2023-04-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Sodium Oxybate Unknown 6 g Oral
Subject Sodium Oxybate Unknown 9 g Oral